Iressa 250 MG
- Principal: AstraZeneca
- Therapeutic Category: Oncology
- Pharmaceutical Form: Tablets
- out of stock
Scientific name: Gefitinib
Pharmaceutical form: tablets 3 X 10's
Indications: locally advanced or metastatic non small cell lung cancer (NSCLC) with activating mutations of EGFR TK
